Epidemiologic study of KRAS mutation in Brazilian patients with advanced or metastatic Non Small Cell Lung Cancer
Study identifier:NIS-OBR-DUM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Epidemiologic study of KRAS mutation in Brazilian patients with advanced or metastatic Non Small Cell Lung Cancer
Medical condition
Non Small Cell Lung Cancer
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
112
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Sept 2009
Primary Completion Date: 01 Apr 2010
Study Completion Date: 01 Apr 2010
Study design
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
Laboratorio Progenetica
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
José Eduardo Pipolo das Neves
AstraZeneca do Brasil, MC Medical Director
